Equities research analysts forecast that CME Group Inc (NASDAQ:CME) will announce $1.65 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for CME Group’s earnings. The lowest EPS estimate is $1.53 and the highest is $1.81. CME Group reported earnings per share of $1.77 during the same quarter last year, which would suggest a negative year-over-year growth rate of 6.8%. The firm is scheduled to announce its next earnings results on Thursday, February 13th.

On average, analysts expect that CME Group will report full year earnings of $6.90 per share for the current fiscal year, with EPS estimates ranging from $6.78 to $7.08. For the next year, analysts anticipate that the company will post earnings of $7.44 per share, with EPS estimates ranging from $7.16 to $7.85. Zacks’ earnings per share averages are an average based on a survey of analysts that follow CME Group.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.45 earnings per share.

A number of equities research analysts have commented on the stock. Citigroup lifted their target price on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Oppenheimer assumed coverage on shares of CME Group in a research report on Monday, September 16th. They issued an “outperform” rating and a $234.00 target price for the company. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Berenberg Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $236.00 to $227.00 in a research report on Thursday, September 19th. Finally, Deutsche Bank lifted their target price on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $203.36.

In other CME Group news, insider Sean Tully sold 7,200 shares of CME Group stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Julie Holzrichter sold 3,436 shares of CME Group stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $216.07, for a total value of $742,416.52. Following the completion of the transaction, the chief operating officer now directly owns 38,704 shares in the company, valued at $8,362,773.28. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,636 shares of company stock valued at $3,001,008. Corporate insiders own 1.20% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Advantage Investment Management LLC boosted its position in CME Group by 119.0% during the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Venturi Wealth Management LLC acquired a new position in CME Group during the third quarter valued at approximately $36,000. Westside Investment Management Inc. acquired a new position in CME Group during the second quarter valued at approximately $38,000. Bartlett & Co. LLC boosted its position in CME Group by 2,471.4% during the third quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 173 shares during the last quarter. Finally, Private Capital Group LLC boosted its position in CME Group by 44.9% during the second quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 75 shares during the last quarter. 84.77% of the stock is currently owned by institutional investors.

NASDAQ:CME traded up $1.43 during trading hours on Thursday, reaching $206.05. The company had a trading volume of 1,059,600 shares, compared to its average volume of 1,508,858. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.14. CME Group has a 52 week low of $161.05 and a 52 week high of $224.91. The firm has a market cap of $71.14 billion, a price-to-earnings ratio of 30.21, a PEG ratio of 3.91 and a beta of 0.18. The firm’s 50 day moving average price is $207.56 and its 200-day moving average price is $202.08.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Tuesday, December 10th will be issued a dividend of $0.75 per share. The ex-dividend date is Monday, December 9th. This represents a $3.00 annualized dividend and a yield of 1.46%. CME Group’s payout ratio is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: NASDAQ Stock Market Explained

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.